Literature DB >> 9916137

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

A Dresner1, D Laurent, M Marcucci, M E Griffin, S Dufour, G W Cline, L A Slezak, D K Andersen, R S Hundal, D L Rothman, K F Petersen, G I Shulman.   

Abstract

To examine the mechanism by which free fatty acids (FFA) induce insulin resistance in human skeletal muscle, glycogen, glucose-6-phosphate, and intracellular glucose concentrations were measured using carbon-13 and phosphorous-31 nuclear magnetic resonance spectroscopy in seven healthy subjects before and after a hyperinsulinemic-euglycemic clamp following a five-hour infusion of either lipid/heparin or glycerol/heparin. IRS-1-associated phosphatidylinositol 3-kinase (PI 3-kinase) activity was also measured in muscle biopsy samples obtained from seven additional subjects before and after an identical protocol. Rates of insulin stimulated whole-body glucose uptake. Glucose oxidation and muscle glycogen synthesis were 50%-60% lower following the lipid infusion compared with the glycerol infusion and were associated with a approximately 90% decrease in the increment in intramuscular glucose-6-phosphate concentration, implying diminished glucose transport or phosphorylation activity. To distinguish between these two possibilities, intracellular glucose concentration was measured and found to be significantly lower in the lipid infusion studies, implying that glucose transport is the rate-controlling step. Insulin stimulation, during the glycerol infusion, resulted in a fourfold increase in PI 3-kinase activity over basal that was abolished during the lipid infusion. Taken together, these data suggest that increased concentrations of plasma FFA induce insulin resistance in humans through inhibition of glucose transport activity; this may be a consequence of decreased IRS-1-associated PI 3-kinase activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916137      PMCID: PMC407880          DOI: 10.1172/JCI5001

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources.

Authors:  H Yki-Järvinen; I Puhakainen; C Saloranta; L Groop; M R Taskinen
Journal:  Am J Physiol       Date:  1991-05

3.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

4.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.

Authors:  D L Rothman; R G Shulman; G I Shulman
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

5.  Activation of phosphatidylinositol 3-kinase by insulin.

Authors:  N B Ruderman; R Kapeller; M F White; L C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation.

Authors:  H Yki-Järvinen; I Puhakainen; V A Koivisto
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

7.  Lipid-induced insulin resistance in cultured hepatoma cells is associated with a decreased insulin receptor tyrosine kinase activity.

Authors:  P Hubert; C Bruneau-Wack; G Cremel; Y Le Marchand-Brustel; C Staedel
Journal:  Cell Regul       Date:  1991-01

8.  Effects of fat on insulin-stimulated carbohydrate metabolism in normal men.

Authors:  G Boden; F Jadali; J White; Y Liang; M Mozzoli; X Chen; E Coleman; C Smith
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Operation of Randle's cycle in patients with NIDDM.

Authors:  S Bevilacqua; G Buzzigoli; R Bonadonna; L S Brandi; M Oleggini; C Boni; M Geloni; E Ferrannini
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

10.  Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats.

Authors:  J Svedberg; P Björntorp; U Smith; P Lönnroth
Journal:  Diabetes       Date:  1992-03       Impact factor: 9.461

View more
  311 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  Free fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation. --to: Steinberg et al. (2002) Vascular function, insulin resistance and fatty acids.

Authors:  Devjit Tripathy; Ahmad Aljada; Paresh Dandona
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

4.  Fatty acid oxidation in human skeletal muscle.

Authors:  Michael D Jensen
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 5.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

Review 6.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 7.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 8.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

9.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

Authors:  Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 10.  Role of ACE inhibitors in treating hypertensive diabetic patients.

Authors:  Dmitri Kirpichnikov; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.